Sanjiv Patel - 03 Nov 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
President and CEO, Director
Signature
/s/ Soo-Yeun Lim, as Attorney-in-Fact
Issuer symbol
RLAY
Transactions as of
03 Nov 2025
Transactions value $
-$434,511
Form type
4
Filing time
04 Nov 2025, 16:10:37 UTC
Previous filing
10 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Patel Sanjiv President and CEO, Director C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE /s/ Soo-Yeun Lim, as Attorney-in-Fact 04 Nov 2025 0001816210

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$435K -62.1K -8.11% $7.00 703K 03 Nov 2025 Direct F1, F2
holding RLAY Common Stock 200K 03 Nov 2025 By The Patel Family Irrevocable Trust of 2019 F3
holding RLAY Common Stock 687K 03 Nov 2025 By The SSP Irrevocable Trust of 2020 F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 136,853 shares of restricted stock units ("RSUs") on October 31, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 136,854 shares underlying RSUs.
F3 These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Remarks:

Exhibit 24 - Power of Attorney